CFP last date
20 January 2025
Call for Paper
February Edition
IJCA solicits high quality original research papers for the upcoming February edition of the journal. The last date of research paper submission is 20 January 2025

Submit your paper
Know more
The week's pick
Responsive image
SFLA-Based Line Balancing and Task Optimization in Master-Slave Controlled Hanger Transportation Systems for Garment Production

Duc Hoang Nguyen
Random Articles
Reseach Article

Identification of Novel CDK Inhibitors by Molecular Docking and Consensus Scoring Approach

by Satyanarayana Kotha, Yesubabu Adimulam, Kiran Kumar Reddi
journal cover thumbnail

International Journal of Computer Applications
Foundation of Computer Science (FCS), NY, USA
Volume 130 - Number 5
Year of Publication: 2015
Authors: Satyanarayana Kotha, Yesubabu Adimulam, Kiran Kumar Reddi
10.5120/ijca2015906972

Satyanarayana Kotha, Yesubabu Adimulam, Kiran Kumar Reddi . Identification of Novel CDK Inhibitors by Molecular Docking and Consensus Scoring Approach. International Journal of Computer Applications. 130, 5 ( November 2015), 24-29. DOI=10.5120/ijca2015906972

@article{ 10.5120/ijca2015906972,
author = { Satyanarayana Kotha, Yesubabu Adimulam, Kiran Kumar Reddi },
title = { Identification of Novel CDK Inhibitors by Molecular Docking and Consensus Scoring Approach },
journal = { International Journal of Computer Applications },
issue_date = { November 2015 },
volume = { 130 },
number = { 5 },
month = { November },
year = { 2015 },
issn = { 0975-8887 },
pages = { 24-29 },
numpages = {9},
url = { https://ijcaonline.org/archives/volume130/number5/23206-2015906972/ },
doi = { 10.5120/ijca2015906972 },
publisher = {Foundation of Computer Science (FCS), NY, USA},
address = {New York, USA}
}
%0 Journal Article
%1 2024-02-06T23:24:34.182983+05:30
%A Satyanarayana Kotha
%A Yesubabu Adimulam
%A Kiran Kumar Reddi
%T Identification of Novel CDK Inhibitors by Molecular Docking and Consensus Scoring Approach
%J International Journal of Computer Applications
%@ 0975-8887
%V 130
%N 5
%P 24-29
%D 2015
%I Foundation of Computer Science (FCS), NY, USA
Abstract

Cyclin Dependent Kinases go about as potential remedial focuses in cancer disease and several efforts are under way to find out more specific, potent and selective CDK inhibitors. In this paper, reported a computational molecular docking approach to screen approved drugs from DrugBank database. Docking and scoring of all compounds was done using Molegro Virtual Docker software, evaluated the binding affinities towards CDK-2, 4, 5 and 9 enzymes 2W9F, 2UZO, 1UNH and 3BLR resulted in variable dock scores. The resultant top 14 hits from a dataset of 1584 approved drugs were found to be more specific towards CDK inhibition. Further, re-scoring of 14 best docked poses followed by a consensus scoring approach retrieved top hits. In this study, tested three different scoring functions such as MolDock score of Molegro software, GOLD score and AutoDock. From the analysis, it was observed that Olmesartan and Telmisartan were reported to have high binding affinities with all CDKs tested.

References
  1. Brun, V., Legraverend, M., Grierson, D. S. 2001. Cyclin-dependent kinase (CDK) inhibitors: development of a general strategy for the construction of 2,6,9- trisubstituted purine libraries. Part 1 Tetrahedron Lett. Vol. 42: 8161-8164.Ding, W. and Marchionini, G. 1997 A Study on Video Browsing Strategies. Technical Report. University of Maryland at College Park.
  2. Fischer, P. M., Endicott, J., Meijer, L. 2003. Cyclin-dependent kinase inhibitors. Prog Cell Cycle Re. Vol.5: 235-248.
  3. Schang, L. M. 2002. Cyclin-dependent kinases as cellular targets for antiviral drugs. J Antimicrob Chemother. Vol. 50: 779-792.Sannella, M. J. 1994 Constraint Satisfaction and Debugging for Interactive User Interfaces. Doctoral Thesis. UMI Order Number: UMI Order No. GAX95-09398., University of Washington.
  4. Sausville, E. A., Johnson, J., Alley, M., Zaharevitz, D., Senderowicz, A. M. 2000. Inhibition of CDKs as a therapeutic modality. Ann N Y Acad Sci. Vol. 910: 207-221.Brown, L. D., Hua, H., and Gao, C. 2003. A widget framework for augmented interaction in SCAPE.
  5. Ekholm, S. V., Reed, S. I. 2000. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol. Vol. 12: 676-684
  6. Davies, T.G., Pratt, D.J., Endicott, J.A., Johnson, L.N., Noble, M.E. 2002. Structure based design of cyclin-dependent kinase inhibitors. Pharmacol The., Vol. 93:125-133.
  7. Noble, M. E., Endicott, J. A. 1999. Chemical inhibitors of cyclin-dependent kinases: insights into design from X-ray crystallographic studies. Pharmacol Ther. Vol.82: 269-278.
  8. Davies, T. G., Tunnah, P., Meijer, L., Marko, D., Eisenbrand, G., Endicott, J. A., Noble, M. E. 2001. Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate. Structure. Vol. 9: 389-397.
  9. DeBondt, H. L., Rosenblatt, J., Jancarik, J., Jones, H. D., Morgan, D. O., Kim, S. H. 1993. Crystal structure of cyclin-dependent kinase 2. Nature. Vol. 363:595-602.
  10. Noble, M. E., Endicott, J. A., Johnson, L. N. 2004. Protein kinase inhibitors: insights into drug design from structure. Science. Vol. 303: 1800-1806.
  11. Sherr, C. J. 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. Vol. 60: 3689-3695.
  12. Takao Horiuchi., Jun Chiba., Kouichi Uoto., Tsunehiko Soga. 2009. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters, Vol.19: 305-308.
  13. Concha Sanchez-Martinez., Chuan Shih., Margaret, M. Faul., Guoxin Zhu., Michael Paal., Carmen Somoza et al. 2003. Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitors. Bioorganic&Medicinal Chemistry Letters. Vol.13: 3835-3839.
  14. Thomas, A. Engler., Kelly Furness., Sushant Malhotra., Concha Sanchez-Martinez., Chuan Shih., Walter Xie., Guoxin Zhu et al. 2003. Novel potent and selective cyclin D1/CDK4 inhibitors:indolo[6,7-a]pyrrolo[3,4-c]carbazoles .Bioorganic & Medicinal Chemistry Letters, Vol.13: 2261-2267.
  15. Kirk, L., Stevens, Michael J. Reno., Jennifer B. Alberti., Daniel J. Price., Laurie S. Kane-Carson., Victoria B. Knick et al. 2008. Synthesis and evaluation of pyrazolo[1,5- b]pyridazines as selective cyclin dependent kinase inhibitors. Bioorganic & Medicinal Chemistry Letters, Vol.18: 5758-5762.
  16. Choi, YJ., Anders, L. 2014. ‘Signaling through cyclin D-dependent kinases. Oncogene. Vol.33: 1890-1903.
  17. Shapiro, GI. 2006. Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol. Vol.24: 1770-1783.
  18. Rene´Thomsen and Mikael H.Christensen. 2006. MolDock: A New Technique for High-Accuracy Molecular Docking. J. Med. Chem. Vol.49: 3315-3321.
  19. Jones, G., Willett, P., Glen, R.C., Leach, A.R., Taylor, R. 1997. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. Vol. 267: 727-748.
  20. Garrett M Morris., David S Goodsell., Robert S Halliday., Ruth Huey., William E Hart., Richard K Belew., Arthur J Olson. 1998. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of computational chemistry. Vol.19:1639-1662.
  21. Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, AC., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., Tang, A., Gabriel, G., Ly, C., Adamjee, S., Dame, ZT., Han, B., Zhou, Y., Wishart, DS. 2014. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. Vol.42:1091-1097.
  22. Kitchen, D.B., Decornez, H., Furr, J.R., Bajorath, J. 2004. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. Vol.3: 935-949.
  23. Wang, R., Lu, Y., Wang, S. 2003. Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem. Vol.46: 2287-2303.
  24. Charifson, P.S., Corkery, J.J., Murcko, M.A., Walters, W.P. 1999. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem. Vol. 42:5100-5109.
  25. Stahl, M., Bohm, H.J. 1998. Development of filter functions for protein-ligand docking. J Mol Graph Model. Vol.16:121-132.
  26. Wang, R., Lu, Y., Fang, X., Wang, S. 2004. An extensive test of 14 scoring functions using the PDB bind refined set of 800 protein-ligand complexes. J Chem Inf Model. Vol.44:2114-2125.
  27. Clark, R.D., Strizhev, A., Leonard, J.M., Blake, J.F., Matthew, J.B. 2002. Consensus scoring for ligand/protein interactions. J Mol Graph Model. Vol. 20: 281-295.
Index Terms

Computer Science
Information Sciences

Keywords

Cyclin-dependent kinases Molecular docking Consensus scoring Binding affinity DrugBank database Olmesartan Telmisartan Protein Data Bank.

Powered by PhDFocusTM